Related Experiment Video
Updated: Feb 27, 2026

08:57
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.7K
Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features
Mustafa Mohamed1, Cyril Fisher1, Khin Thway1
1Sarcoma Unit, Royal Marsden Hospital, London, UK.
Annals of Diagnostic Pathology
|June 27, 2017
Summary
Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (SEF) are rare soft tissue tumors. This review details their distinct morphology, immunohistochemistry, and genetic fusions, emphasizing diagnostic accuracy for effective treatment and management.
Area of Science:
- Soft tissue pathology
- Oncology
- Molecular genetics
Background:
- Low-grade fibromyxoid sarcoma (LGFMS) is a spindle cell neoplasm often found in deep soft tissues.
- LGFMS is frequently associated with specific genetic translocations, including FUS-CREB3L2, FUS-CREB3L1, and EWSR1-CREB3L1.
- Sclerosing epithelioid fibrosarcoma (SEF) is a related fibroblastic neoplasm with overlapping features and genetic alterations.
Purpose of the Study:
- To review the distinct morphological and immunohistochemical features of LGFMS and SEF.
- To discuss the genetic and molecular underpinnings of these tumors, including common fusion genes.
- To highlight the importance of accurate differential diagnosis for optimal patient management.
Main Methods:
- Review of literature on LGFMS and SEF.
- Analysis of morphological characteristics and immunohistochemical profiles.
- Examination of genetic and molecular findings, including specific translocations and fusion transcripts.
Main Results:
- LGFMS typically presents as bland spindle cells with myxoid and fibrous areas, consistently expressing MUC4.
- SEF shows epithelioid cells in sclerotic stroma, with some cases exhibiting LGFMS-like areas and FUS-CREB3L2 fusions.
- Both tumor types share specific genetic rearrangements and MUC4 expression in a significant subset of SEF cases.
Conclusions:
- Accurate diagnosis of LGFMS and SEF is crucial due to their potential for recurrence and metastasis.
- Understanding the shared and distinct molecular features aids in differential diagnosis.
- Surgical resection with clear margins is the primary treatment modality for these tumors.

